Literature DB >> 33149083

Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart.

Kenneth Cusi1,2, Eddison Godinez Leiva2.   

Abstract

Entities:  

Year:  2020        PMID： 33149083     DOI： 10.1097/MOL.0000000000000717

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


× No keyword cloud information.
  4 in total

Review 1.  Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Fasiha Kanwal; Jay H Shubrook; Leon A Adams; Kim Pfotenhauer; Vincent Wai-Sun Wong; Eugene Wright; Manal F Abdelmalek; Stephen A Harrison; Rohit Loomba; Christos S Mantzoros; Elisabetta Bugianesi; Robert H Eckel; Lee M Kaplan; Hashem B El-Serag; Kenneth Cusi
Journal:  Gastroenterology       Date:  2021-09-20       Impact factor: 33.883

Review 2.  The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD.

Authors:  Chandani Patel Chavez; Kenneth Cusi; Sushma Kadiyala
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

3.  VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis.

Authors:  Rotonya M Carr
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

4.  Low testosterone and cardiometabolic risks in a real-world study of US male firefighters.

Authors:  Sushant M Ranadive; Adriana Lofrano-Porto; Edgard M K V K Soares; Lauren Eagan; Luiz Guilherme Grossi Porto; Denise L Smith
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.